Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 3 weeks ago
127 views
Shared 1 month ago
127 views
Shared 2 months ago
76K views
Shared 2 months ago
415 views
Shared 3 months ago
542 views
Shared 3 months ago
569 views
Shared 3 months ago
595 views
Shared 3 months ago
144K views
Shared 4 months ago
690 views
Shared 4 months ago
371 views
Shared 5 months ago
209K views
Shared 6 months ago
322 views
Shared 8 months ago
473K views
Shared 8 months ago
223 views
Shared 8 months ago
97 views
Shared 9 months ago
802 views
Shared 9 months ago
1.9K views
Shared 10 months ago
432 views
Shared 11 months ago
604 views
Shared 11 months ago
119K views
Shared 11 months ago
154 views
Shared 11 months ago
41K views
Shared 11 months ago
362 views